BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30796168)

  • 1. Frequency, Determinants, and Costs of Recommendations for Additional Imaging in Clinical
    Alesawi HM; Yakar D; Glaudemans AWJM; Kwee TC
    J Nucl Med; 2019 Sep; 60(9):1228-1233. PubMed ID: 30796168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations in Clinical
    Alesawi HM; Kwee TC; Glaudemans AWJM; Yakar D
    J Am Coll Radiol; 2018 Sep; 15(9):1269-1275. PubMed ID: 30064891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for additional imaging of abdominal imaging examinations: frequency, benefit, and cost.
    Heinz SA; Kwee TC; Yakar D
    Eur Radiol; 2020 Feb; 30(2):1137-1144. PubMed ID: 31451972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
    Shmidt E; Nehra V; Lowe V; Oxentenko AS
    BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin.
    Mulders-Manders CM; Kouijzer IJ; Janssen MJ; Oyen WJ; Simon A; Bleeker-Rovers CP
    Q J Nucl Med Mol Imaging; 2021 Mar; 65(1):51-58. PubMed ID: 31271266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, appropriateness, and consequences of recommendations for additional imaging tests in oncological PET/CT reports.
    Shinagare AB; Shyn PB; Sadow CA; Wasser EJ; Catalano P
    Clin Radiol; 2013 Feb; 68(2):155-61. PubMed ID: 22892243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.
    Vrachimis A; Stegger L; Wenning C; Noto B; Burg MC; Konnert JR; Allkemper T; Heindel W; Riemann B; Schäfers M; Weckesser M
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1765-72. PubMed ID: 27059853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact and diagnostic accuracy of 2-[
    Motara H; Olusoga T; Russell G; Jamieson S; Ahmed S; Brindle N; Pillai A; Scarsbrook AF; Patel CN; Chowdhury FU
    Clin Radiol; 2017 Jan; 72(1):63-73. PubMed ID: 27637430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Brain Metastases on Follow-up
    Nia ES; Garland LL; Eshghi N; Nia BB; Avery RJ; Kuo PH
    J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of
    Albano D; Bosio G; Giubbini R; Bertagna F
    Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of early 18F-FDG PET/CT in therapeutic management and ongoing risk stratification of high/intermediate-risk thyroid carcinoma.
    Triviño Ibáñez EM; Muros MA; Torres Vela E; Llamas Elvira JM
    Endocrine; 2016 Mar; 51(3):490-8. PubMed ID: 26224589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
    Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
    J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of
    Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Economic Impact of Incidental Findings on
    Adams SJ; Rakheja R; Bryce R; Babyn PS
    Can Assoc Radiol J; 2018 Feb; 69(1):63-70. PubMed ID: 29458956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
    Liu Y
    Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic errors in clinical FDG-PET/CT.
    Alotaibi NA; Yakar D; Glaudemans AWJM; Kwee TC
    Eur J Radiol; 2020 Nov; 132():109296. PubMed ID: 33002816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Antibiotic Treatment Affect the Diagnostic Accuracy of
    Kagna O; Kurash M; Ghanem-Zoubi N; Keidar Z; Israel O
    J Nucl Med; 2017 Nov; 58(11):1827-1830. PubMed ID: 28473596
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging
    Okuyucu K; Ince S; Alagoz E; Emer O; San H; Balkan E; Ayan A; Meric C; Haymana C; Acıkel C; Gunalp B; Karacalioglu AO; Arslan N
    Hell J Nucl Med; 2016; 19(3):208-217. PubMed ID: 27824959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis.
    Kouijzer IJE; Berrevoets MAH; Aarntzen EHJG; de Vries J; van Dijk APJ; Oyen WJG; de Geus-Oei LF; Bleeker-Rovers CP
    Nucl Med Commun; 2018 Aug; 39(8):747-752. PubMed ID: 29762262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.